Please login to the form below

bipolar disorder

This page shows the latest bipolar disorder news and features for those working in and with pharma, biotech and healthcare.

First digital medicine approved in the US

Abilify MyCite is the latest iteration of antipsychotic blockbuster Abilify (aripiprazole) to reach the market, and is approved for the same indications as its parent products - schizophrenia, bipolar I disorder and

Latest news

Lundbeck and Otsuka start phase III for Rexulti in bipolar

Lundbeck and Otsuka start phase III for Rexulti in bipolar. Drug is also in phase II trial to treat PTSD patients. ... Otsuka and co-development partner Lundbeck have started two phase III trials of their atypical antipsychotic Rexulti in bipolar disorder
Lundbeck partners with 23andMe on first-of-its-kind study

The US project will involve 25, 000 patients and combine data from genetics, cognitive tests and online surveys to explore how genetics is related to major depressive disorder (MDD), bipolar depression ... Anders Gersel Pedersen, executive VP, research
Otsuka refiles 'digital' medicine for mental illness

Abilify is approved to treat schizophrenia, bipolar disorder and major depressive disorder.
FDA knocks-back Otsuka's digital pill plans

Otsuka had submitted the device for approval to measure medication adherence to Abilify (aripiprazole) in patients with schizophrenia, as an acute treatment of manic and mixed episodes associated with bipolar I ... disorder and as an adjunctive treatment
Rare disease therapies head the ‘class of 2015’

EU. cariprazine. Vraylar. schizophrenia / bipolar disorder. dopamine D3/D2 receptor partial agonist. ... hypoactive sexual desire disorder. serotonin 5-HT1a agonist / 5-HT2a antagonist. Sprout Pharmaceuticals.

More from news
Approximately 7 fully matching, plus 84 partially matching documents found.

Latest Intelligence

Drug pricing in Ireland

As such, patients with coronary syndromes, multiple sclerosis, bipolar disorder and Hepatitis C were being denied access to effective treatments, while treatments for other diseases were also subject to restrictions.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH

there’ s an abundance of smart thinking on how to improve the lives of people who struggle with major depression, schizophrenia, bipolar disorder, and other serious conditions.
How health behaviours and clinical outcomes are related

Patients suffering from post-traumatic stress disorder, schizophrenia, bipolar disorder and depression also have more positive outcomes with higher patient activation levels.
How health behaviours and clinical outcomes are related

Patients suffering from post-traumatic stress disorder, schizophrenia, bipolar disorder and depression also have more positive outcomes with higher patient activation levels.
AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH

there’ s an abundance of smart thinking on how to improve the lives of people who struggle with major depression, schizophrenia, bipolar disorder, and other serious conditions.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Senior Account Manager / Account Director: Great salary and bebefits

Senior Account Manager – Med Comms – Kent: Salary TBC

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Medical Writer - (London, Brighton or Copenhagen): Competitive

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior Medical Writer: Great salary and bebefits

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Senior Medical Writer: Great salary and benefits

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Account Manager – Med Comms – London: Salary TBC

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Senior Account Manager or AD - Medical Communications: Salary TBC

Scientific Director: Great salary and bebefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Senior Programme Executive: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Shaping healthcare: Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes...
No Voice, No Choice: Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Pharma’s isolated islands of innovation: With service design and technology often failing the patient, why perspective on improving outcomes need to change...